Another Early-Stage VC Win: Pliant Raises $45m For Fibrosis Startup

As venture capital investment in biotechnology skyrockets, the amount of money that companies can raise in first-time financings also is soaring to new heights, and the fibrosis-focused startup Pliant Therapeutics Inc. with its $45m Series A round is no exception to the new biotech VC rule.